该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
内部交易: $凯姆布雷克斯(CBM)$ 2013-02-25,总裁, Cambrex Profarmaco,RUSSOLO PAOLO ,期权,8500普通股, $7.39
内部交易: $凯姆布雷克斯(CBM)$ 2013-02-12,Managing Director-Profarmaco,Magnini Aldo ,卖出,16199普通股, $12.00
$凯姆布雷克斯(CBM)$ 美东时间 2013-02-07 08:30 Q4 2012 Cambrex Earnings Conference Call
内部交易: $凯姆布雷克斯(CBM)$ 2012-11-09,Managing Director-Profarmaco,Magnini Aldo ,卖出,28750普通股, $9.71
内部交易: $凯姆布雷克斯(CBM)$ 2012-11-09,Managing Director-Profarmaco,Magnini Aldo ,期权,28750普通股, $4.79
内部交易: $凯姆布雷克斯(CBM)$ 2012-04-25,Director,BETHUNE DAVID R ,期权,2000普通股, $4.15
内部交易: $凯姆布雷克斯(CBM)$ 2012-04-04,Director,TOMBROS PETER G ,期权,2000普通股, $4.72